Gii Assay is a full-service development programme designed to help innovators build high-performance assays on Gii, iGii’s advanced carbon nanomaterial.
Gii Assay is built around deep knowledge of Gii and its unique material properties. It offers access to a growing pipeline of more than 75 assays already developed on Gii, giving partners a head start with proven examples across multiple formats and use cases.
Gii Assay takes customers from screening through to pre-clinical validation, with the flexibility to continue through full commercialisation in partnership with iGii’s trusted network. The service is designed to support early-stage development internally, with later stages led through customer partnerships and specialist collaborators.
Gii Assay is built around deep knowledge of Gii and its unique material properties. The programme is already advancing a growing pipeline of assays internally, the broader Gii assay pipeline is scheduled for phased release following the company’s next growth stage.
From early insight to scalable integration, supporting every step
Our experts develop assays that showcase Gii’s groundbreaking capabilities in sensitivity, stability, and ani-fouling performance.
Unparalleled insight into maximising its unique properties and elevating high performance.
From antibody screening to assay feasibility and optimisation, manage the entire early-stage assay development process.
Our streamlined process and proprietary technology deliver unmatched value for both startups and established enterprises.
Work within your facilities, transferring knowledge directly and preparing your team to leverage Gii technology independently.
Compatible with a wide range of functionalisation strategies and sensor designs
Gii Assay accelerates diagnostic platform development by combining advanced material science with hands-on expertise. Enabled by Gii’s high signal response and natural antifouling properties, teams can build robust assays faster, with less risk. With 75+ validated assays and expert support, Gii Assay lowers costs and shortens the path to commercial readiness.